Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$917K Buy
2,775
+48
+2% +$15.5K 0.05% 225
2025
Q1
$897K Buy
2,727
+268
+11% +$80.7K 0.06% 221
2024
Q4
$679K Sell
2,459
-582
-19% -$186K 0.04% 248
2024
Q3
$1.05M Buy
3,041
+96
+3% +$33K 0.07% 185
2024
Q2
$973K Buy
2,945
+28
+1% +$9.65K 0.07% 181
2024
Q1
$1.06M Buy
2,917
+419
+17% +$138K 0.08% 171
2023
Q4
$748K Buy
2,498
+193
+8% +$56.4K 0.06% 200
2023
Q3
$659K Buy
2,305
+727
+46% +$207K 0.06% 197
2023
Q2
$443K Buy
1,578
+313
+25% +$81.5K 0.04% 242
2023
Q1
$323K Buy
1,265
+8
+0.6% +$2.33K 0.04% 270
2022
Q4
$417K Buy
1,257
+55
+5% +$17.4K 0.05% 216
2022
Q3
$334K Buy
+1,202
New +$338K 0.04% 238

Other funds holding CI

Graypoint LLC's CI Position: Q2 2025 in Review

Graypoint LLC increased its Cigna (CI) stake by 1.8% in Q2 2025, buying an estimated $15.5K and bringing the position to 2,775 shares worth $917K. The position accounts for 0.05% of the portfolio, ranked #225.

Graypoint LLC first reported a position in CI in Q3 2022 and has held it in 12 quarters since. The position peaked at $1.06M in Q1 2024. 1,733 funds tracked by Wall St. Rank hold CI as of Q2 2025.

  • Graypoint LLC held 2,775 shares of Cigna worth $917K as of Q2 2025.
  • Graypoint LLC bought 48 Cigna shares in Q2 2025, an estimated $15.5K.
  • Cigna made up 0.05% of Graypoint LLC's portfolio in Q2 2025, its #225 holding.
  • Graypoint LLC first reported a position in Cigna in Q3 2022 and has held it in 12 quarters since.
  • Graypoint LLC's Cigna position peaked at $1.06M in Q1 2024.
  • 1,733 funds tracked by Wall St. Rank held Cigna as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.